symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
TMDX,43.45,1.565826,786290,1417790880,0,40.45-99.63,-0.37,"TransMedics Group, Inc.",USD,0001756262,US89377M1099,89377M109,NASDAQ Global Market,NASDAQ,Medical Devices,https://www.transmedics.com,"TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.",Dr. Waleed H. Hassanein M.D.,Healthcare,US,212,978 552 0900,200 Minuteman Road,Andover,MA,01810,10.3145,58.7555,https://financialmodelingprep.com/image-stock/TMDX.png,2019-05-02,False,False,True,False,False
